Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Hydrocodone
Drug ID BADD_D01084
Description Hydrocodone is a synthetic opioid derivative of codeine.[T116] It is commonly used in combination with [acetaminophen] to control moderate to severe pain. Historically, hydrocodone has been used as a cough suppressant although this has largely been replaced by [dextromethorphan] in current cough and cold formulations. Hydrocodone's more potent metabolite, [hydromorphone] has also found wide use as an analgesic and is frequently used in cases of severe pain. The FDA first approved Hydrocodone for use as part of the cough suppressant syrup Hycodan in March of 1943.[L9025]
Indications and Usage Hydrocodone is indicated for the management of acute pain, sometimes in combination with [acetaminophen] or [ibuprofen], as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.[label,L7991]
Marketing Status approved; illicit; investigational
ATC Code R05DA03
DrugBank ID DB00956
KEGG ID D08045
MeSH ID D006853
PubChem ID 5284569
TTD Drug ID D0X5KF
NDC Product Code 81842-617
UNII 6YKS4Y3WQ7
Synonyms Hydrocodone | Hydrocodon | Dihydrocodeinone | Dicodid | Robidone | Hydrocodone Bitartrate | Hydrocodone Tartrate (1:1), Hydrate (2:5) | Hydrocodeinonebitartrate | Hydrocon | Codinovo | Hycodan | Hycon
Chemical Information
Molecular Formula C18H21NO3
CAS Registry Number 125-29-1
SMILES CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal distension07.01.04.0010.000372%
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.0030.000532%
Agranulocytosis01.02.03.001--Not Available
Amnesia19.20.01.001; 17.03.02.0010.000073%
Anaphylactic reaction24.06.03.006; 10.01.07.0010.000073%
Anxiety19.06.02.0020.002808%
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Body temperature increased13.15.01.001--Not Available
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000109%Not Available
Chest discomfort02.02.02.009; 22.12.02.002; 08.01.08.0190.000248%Not Available
Completed suicide19.12.01.001; 08.04.01.0100.000219%Not Available
Constipation07.02.02.001--
Cough22.02.03.001--
Deafness04.02.01.001--Not Available
Dehydration14.05.05.001--
Depression19.15.01.0010.000182%
Dermatitis23.03.04.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Drug abuse19.07.06.0100.000328%Not Available
Drug dependence19.07.06.0110.008568%Not Available
Drug hypersensitivity10.01.01.0010.001772%Not Available
Drug ineffective08.06.01.0060.002888%Not Available
Drug interaction08.06.03.001--Not Available
Drug withdrawal syndrome19.07.06.013; 08.06.02.0040.003814%Not Available
Drug withdrawal syndrome neonatal19.07.06.014; 18.04.13.001; 08.06.02.0080.000401%Not Available
Dry mouth07.06.01.002--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages